BRIACELL THERAPEUTICS CORP. Earnings Per Share (Basic)
BRIACELL THERAPEUTICS CORP. (BCTX) reported Earnings Per Share (Basic) of -$0.99 per share for the 3-month period ending 2026-04-30, per its 10-Q filed 2026-06-09.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-06-09
- BRIACELL THERAPEUTICS CORP. earnings per share, basic for the quarter ending 2026-04-30 was -$0.99.
- BRIACELL THERAPEUTICS CORP. earnings per share, basic for the quarter ending 2026-01-31 was -$2.58.
- BRIACELL THERAPEUTICS CORP. earnings per share, basic for the quarter ending 2025-10-31 was -$4.35.
- BRIACELL THERAPEUTICS CORP. earnings per share, basic for the quarter ending 2025-04-30 was -$16.42, a 1119.88% decline year-over-year.
- BRIACELL THERAPEUTICS CORP. earnings per share, basic for fiscal 2025 was -$62.19.
- BRIACELL THERAPEUTICS CORP. earnings per share, basic for fiscal 2024 was -$43.68.
- BRIACELL THERAPEUTICS CORP. earnings per share, basic for fiscal 2023 was -$1.30.
- BRIACELL THERAPEUTICS CORP. earnings per share, basic for fiscal 2022 was -$1.73.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | -$0.99 10-Q · filed 2026-06-09 | -$5.73 10-Q · filed 2026-06-09 | ||||||
| 2026-01-31 | -$2.58 10-Q · filed 2026-03-10 | |||||||
| 2025-10-31 | -$4.35 10-Q · filed 2025-12-11 | |||||||
| 2025-07-31 | -$62.19 10-K · filed 2025-10-16 | |||||||
| 2025-04-30 | -$16.42 10-Q · filed 2026-06-09 | -$1.64 10-Q · filed 2025-06-16 | -$67.08 10-Q · filed 2026-06-09 | -$6.70 10-Q · filed 2025-06-16 | ||||
| 2025-01-31 | -$23.31 10-Q · filed 2026-03-10 | -$2.33 10-Q · filed 2025-03-12 | -$54.35 10-Q · filed 2026-03-10 | -$5.44 10-Q · filed 2025-03-12 | ||||
| 2024-10-31 | -$32.67 10-Q · filed 2025-12-11 | -$0.22 10-Q · filed 2024-12-16 | $5.44 derived: net income ÷ weighted average shares · filed 2025-12-11 | $10.50 derived: net income ÷ weighted average shares · filed 2025-12-11 | ||||
| 2024-07-31 | $0.44 derived: net income ÷ weighted average shares · filed 2025-10-16 | -$0.59 derived: net income ÷ weighted average shares · filed 2025-10-16 | -$43.68 10-K · filed 2025-10-16 | -$0.29 10-K · filed 2024-10-29 | ||||
| 2024-04-30 | $1.61 10-Q · filed 2025-06-16 | $0.11 10-Q · filed 2024-06-14 | -$3.36 10-Q · filed 2025-06-16 | -$0.22 10-Q · filed 2024-06-14 | ||||
| 2024-01-31 | -$10.64 10-Q · filed 2025-03-12 | -$0.71 10-Q · filed 2024-03-18 | -$5.04 10-Q · filed 2025-03-12 | -$0.33 10-Q · filed 2024-03-18 | ||||
| 2023-10-31 | $0.38 10-Q · filed 2024-12-16 | $0.22 derived: net income ÷ weighted average shares · filed 2024-12-16 | -$0.08 derived: net income ÷ weighted average shares · filed 2024-12-16 | -$0.84 derived: net income ÷ weighted average shares · filed 2024-12-16 | ||||
| 2023-07-31 | -$0.15 derived: net income ÷ weighted average shares · filed 2024-10-29 | -$0.47 derived: net income ÷ weighted average shares · filed 2024-10-29 | -$1.23 derived: net income ÷ weighted average shares · filed 2024-10-29 | -$1.30 10-K · filed 2024-10-29 | ||||
| 2023-04-30 | -$0.32 10-Q · filed 2024-06-14 | -$1.08 derived: net income ÷ weighted average shares · filed 2024-06-14 | -$1.15 10-Q · filed 2024-06-14 | |||||
| 2023-01-31 | -$0.77 10-Q · filed 2024-03-18 | -$0.84 10-Q · filed 2024-03-18 | ||||||
| 2022-10-31 | -$0.07 10-Q · filed 2023-12-14 | |||||||
| 2022-07-31 | -$1.73 10-K · filed 2023-10-25 | |||||||
| 2022-01-31 | $0.71 10-Q · filed 2023-03-16 | -$1.05 10-Q · filed 2023-03-16 | ||||||
| 2021-10-31 | -$1.81 10-Q · filed 2022-12-14 | |||||||
| 2021-07-31 | -$3.06 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |